PT1919883E - N-óxidos como pró-medicamentos de derivados de piperazina & piperidina - Google Patents
N-óxidos como pró-medicamentos de derivados de piperazina & piperidina Download PDFInfo
- Publication number
- PT1919883E PT1919883E PT06778284T PT06778284T PT1919883E PT 1919883 E PT1919883 E PT 1919883E PT 06778284 T PT06778284 T PT 06778284T PT 06778284 T PT06778284 T PT 06778284T PT 1919883 E PT1919883 E PT 1919883E
- Authority
- PT
- Portugal
- Prior art keywords
- art
- relates
- disease
- manufacture
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70982105P | 2005-08-22 | 2005-08-22 | |
EP05107671 | 2005-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1919883E true PT1919883E (pt) | 2009-03-26 |
Family
ID=39246895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT06778284T PT1919883E (pt) | 2005-08-22 | 2006-08-21 | N-óxidos como pró-medicamentos de derivados de piperazina & piperidina |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1919883B1 (pt) |
JP (1) | JP2009504799A (pt) |
KR (1) | KR20080046205A (pt) |
AT (1) | ATE417834T1 (pt) |
AU (1) | AU2006283882B2 (pt) |
CA (1) | CA2621158A1 (pt) |
DE (1) | DE602006004363D1 (pt) |
DK (1) | DK1919883T3 (pt) |
ES (1) | ES2318783T3 (pt) |
HR (1) | HRP20090143T3 (pt) |
IL (1) | IL188903A0 (pt) |
NO (1) | NO20081435L (pt) |
PL (1) | PL1919883T3 (pt) |
PT (1) | PT1919883E (pt) |
RU (1) | RU2394821C2 (pt) |
SI (1) | SI1919883T1 (pt) |
WO (1) | WO2007023141A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7423040B2 (en) | 2005-02-18 | 2008-09-09 | Irene Eijgendaal | Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same |
US7964604B2 (en) | 2005-02-18 | 2011-06-21 | Solvay Pharmaceuticals B.V. | Bifeprunox mesylate maintenance dose compositions and methods for using the same |
US7786126B2 (en) | 2006-06-16 | 2010-08-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising SLV308 and a dopamine agonist |
MY148457A (en) * | 2006-06-16 | 2013-04-30 | Solvay Pharm Bv | Combination preparations comprising slv308 and a dopamine agonist |
EP2059244A1 (en) | 2006-08-31 | 2009-05-20 | Solvay Pharmaceuticals B.V. | Titration schedule for bifeprunox for treating schizophrenia and kits for use therein |
EP2146961B1 (en) * | 2007-04-12 | 2014-01-29 | IVAX International GmbH | N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles |
US20110105523A1 (en) * | 2008-01-15 | 2011-05-05 | Van Stuivenberg Herman H | Bifeprunox derivatives |
WO2011023796A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Healthcare Products B.V. | Bifeprunox for treating addiction |
US9012476B2 (en) | 2011-12-08 | 2015-04-21 | IVAX International GmbH | Hydrobromide salt of pridopidine |
EA027748B1 (ru) | 2012-04-04 | 2017-08-31 | Тева Фармасьютикалз Интернэшнл Гмбх | Применение придопидина в комбинации с тетрабеназином для лечения двигательных нарушений и ожирения |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE503170A (pt) * | 1975-09-02 | |||
DE69736704T2 (de) * | 1996-03-29 | 2007-09-13 | Duphar International Research B.V. | Piperazin- und piperidin- derivate |
UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
HUP0302016A2 (hu) * | 2000-05-12 | 2003-09-29 | Solvay Pharmaceuticals B.V. | Piperazin és piperidinvegyületek, ezeket tartalmazó gyógyászati készítmények, eljárás elżállításukra és alkalmazásuk |
US20050085510A1 (en) * | 2002-01-16 | 2005-04-21 | Telefonaktiebolaget Lm Ericsson (Publ) | Prucalopride-n-oxide |
-
2006
- 2006-08-21 RU RU2008110945/04A patent/RU2394821C2/ru not_active IP Right Cessation
- 2006-08-21 AT AT06778284T patent/ATE417834T1/de active
- 2006-08-21 PT PT06778284T patent/PT1919883E/pt unknown
- 2006-08-21 JP JP2008527453A patent/JP2009504799A/ja active Pending
- 2006-08-21 DK DK06778284T patent/DK1919883T3/da active
- 2006-08-21 SI SI200630214T patent/SI1919883T1/sl unknown
- 2006-08-21 ES ES06778284T patent/ES2318783T3/es active Active
- 2006-08-21 DE DE602006004363T patent/DE602006004363D1/de active Active
- 2006-08-21 CA CA002621158A patent/CA2621158A1/en not_active Abandoned
- 2006-08-21 AU AU2006283882A patent/AU2006283882B2/en not_active Ceased
- 2006-08-21 PL PL06778284T patent/PL1919883T3/pl unknown
- 2006-08-21 KR KR1020087006996A patent/KR20080046205A/ko not_active Application Discontinuation
- 2006-08-21 EP EP06778284A patent/EP1919883B1/en active Active
- 2006-08-21 WO PCT/EP2006/065477 patent/WO2007023141A1/en active Application Filing
-
2008
- 2008-01-21 IL IL188903A patent/IL188903A0/en unknown
- 2008-03-19 NO NO20081435A patent/NO20081435L/no not_active Application Discontinuation
-
2009
- 2009-03-10 HR HR20090143T patent/HRP20090143T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK1919883T3 (da) | 2009-04-14 |
KR20080046205A (ko) | 2008-05-26 |
ATE417834T1 (de) | 2009-01-15 |
CA2621158A1 (en) | 2007-03-01 |
EP1919883A1 (en) | 2008-05-14 |
EP1919883B1 (en) | 2008-12-17 |
PL1919883T3 (pl) | 2009-06-30 |
RU2008110945A (ru) | 2009-09-27 |
WO2007023141A1 (en) | 2007-03-01 |
DE602006004363D1 (de) | 2009-01-29 |
IL188903A0 (en) | 2008-04-13 |
AU2006283882A1 (en) | 2007-03-01 |
ES2318783T3 (es) | 2009-05-01 |
HRP20090143T3 (en) | 2009-04-30 |
RU2394821C2 (ru) | 2010-07-20 |
SI1919883T1 (sl) | 2009-04-30 |
AU2006283882B2 (en) | 2011-06-23 |
NO20081435L (no) | 2008-05-16 |
JP2009504799A (ja) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090143T3 (en) | N-oxides as prodrugs of piperazine&piperidine derivatives | |
TW200505907A (en) | Piperidine-benzenesulfonamide derivatives | |
NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
NO20051826L (no) | Heterosyklisk substituerte piperaziner for behandling av schizofreni | |
UA85707C2 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
UA83899C2 (uk) | Сполуки імідазолу для лікування нейродегенеративних розладів | |
ATE493407T1 (de) | 3-(heteroaryloxy)-2-alkyl-1- azabicycloalkylderivate als alpha.7-nachr- liganden zur behandlung von zns-erkrankungen | |
WO2005079802A8 (en) | Bipyridyl amides as modulators of metabotropic glutamate receptor-5 | |
NO20060768L (no) | 1-(2-amino-benzol)-piperazinderivater som glycinopptaks-inhibitorer for behandling av psykoser | |
TW200420550A (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
ES2162257T3 (es) | N-aminoalquildibenzofurancarboxamidas como ligandos especificos del subtipo de receptor de la dopamina. | |
IL186777A0 (en) | (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor | |
NO20072046L (no) | Halogensubstituerte benzodiazepinderivater | |
IL176914A0 (en) | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
NO20072972L (no) | Terapeutiske pyrazolo[3,4-B]pyridiner og indazoler | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
ZA200906573B (en) | Dibenzo[1,4]oxazapine compounds | |
UA94718C2 (ru) | N-оксиды в качестве пролекарств производных пиперазина и пиперидина | |
ATE496534T1 (de) | Difluorierte piperidine zur behandlung von morbus alzheimer und verwandten leiden | |
UA96756C2 (en) | N-oxides of pyridylmethylpiperazine and -piperidine derivatives | |
DE60307286D1 (de) | Verfahren zur Herstellung von 2-Methyl Piperazine Derivaten. | |
BRPI0514077A (pt) | derivados de benzilóxi como inibidores de maob | |
IL188109A0 (en) | Chloro-substituted guanidines | |
MXPA06000193A (es) | Derivados de imidazol iii. | |
DE69906728D1 (de) | Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen |